GSK (LON:GSK) Share Price Crosses Above Two Hundred Day Moving Average - Here's Why

GSK plc (LON:GSK - Get Free Report)'s stock price passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 1,413.02 ($19.13) and traded as high as GBX 1,445.50 ($19.57). GSK shares last traded at GBX 1,436.16 ($19.44), with a volume of 26,820,320 shares changing hands.

Wall Street Analyst Weigh In

GSK has been the topic of a number of analyst reports. Shore Capital reiterated a "buy" rating on shares of GSK in a research report on Wednesday, April 30th. JPMorgan Chase & Co. reiterated an "underweight" rating on shares of GSK in a report on Friday, March 28th. One investment analyst has rated the stock with a sell rating and five have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of GBX 1,862.50 ($25.22).

GSK Price Performance

The stock has a 50-day simple moving average of GBX 1,429.79 and a 200 day simple moving average of GBX 1,414.34. The company has a market cap of £57.22 billion, a PE ratio of 22.78, a P/E/G ratio of 1.24 and a beta of 0.31. The company has a quick ratio of 0.73, a current ratio of 0.81 and a debt-to-equity ratio of 114.64.

GSK (LON:GSK - Get Free Report) last posted its earnings results on Wednesday, April 30th. The company reported GBX 44.90 ($0.61) EPS for the quarter. GSK had a net margin of 8.02% and a return on equity of 18.08%. Equities analysts expect that GSK plc will post 175.980975 EPS for the current year.

Insider Activity at GSK

In other GSK news, insider Emma Walmsley sold 5,473 shares of the firm's stock in a transaction that occurred on Tuesday, May 6th. The shares were sold at an average price of GBX 1,449 ($19.62), for a total value of £79,303.77 ($107,370.39). Also, insider Jonathan Symonds purchased 1,350 shares of the company's stock in a transaction on Friday, June 20th. The stock was acquired at an average price of GBX 1,435 ($19.43) per share, with a total value of £19,372.50 ($26,228.68). In the last 90 days, insiders have bought 1,905 shares of company stock worth $2,732,835. 1.61% of the stock is currently owned by company insiders.

About GSK

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.